{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/cellulitis-acute/prescribing-information/amoxicillin/","result":{"pageContext":{"chapter":{"id":"78de19b8-8e80-551f-8112-456ce2e25bb0","slug":"amoxicillin","fullItemName":"Amoxicillin","depth":2,"htmlHeader":"<!-- begin field 44227b11-355f-4ea2-a6ae-27ade1155223 --><h2>Amoxicillin</h2><!-- end field 44227b11-355f-4ea2-a6ae-27ade1155223 -->","summary":"","htmlStringContent":"<!-- begin item 83d26458-5442-4b5b-9d97-cf0d2e63b835 --><!-- end item 83d26458-5442-4b5b-9d97-cf0d2e63b835 -->","topic":{"id":"c0841d82-0a64-5b27-81dc-9a825d85f1bf","topicId":"6db61277-29ef-49cc-bad1-d0d78d0afc10","topicName":"Cellulitis - acute","slug":"cellulitis-acute","lastRevised":"Last revised in January 2021","chapters":[{"id":"84376fdb-da2b-561d-bb40-28b5b1a7e975","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"bdf35905-533d-5cb1-bd18-9c1575427a25","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"d6c8c4bd-9395-5840-83c7-67ddfeabdf85","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"59d003f6-dd50-5136-b5c2-c2ea4e4b6f01","slug":"changes","fullItemName":"Changes"},{"id":"f79ca51e-9432-56b1-95de-92ed6133be2b","slug":"update","fullItemName":"Update"}]},{"id":"05002b30-8200-5ccf-b9da-7c96acdb65bd","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"fefb70b6-1d32-5e70-afc6-291fa40b3137","slug":"goals","fullItemName":"Goals"},{"id":"cf84220a-f381-5ca1-aa76-ffb99c4959f6","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"aa32cbb7-29d6-58b6-bcde-7702767672ec","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"7e039433-2afe-5980-93f0-c20c41976610","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"d1411fdd-dc83-5f20-9fa4-ad67b69c195a","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"ce40a600-51e8-5b3a-86c2-d127f03c16eb","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"ff60c523-3d6f-5766-8508-98e8cdcf08f5","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"8e8cfe4a-13f2-573c-ab45-7231016746c4","slug":"definition","fullItemName":"Definition"},{"id":"2b7befe3-0fef-5d4e-b00d-bad6742fb93c","slug":"causes","fullItemName":"Causes"},{"id":"96971948-f52b-561c-84f8-8600f3eff2d4","slug":"prevalence","fullItemName":"Prevalence"},{"id":"4749dc8a-3f24-5e65-a0a3-5d7665ef3085","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"ad3d41f6-595b-505c-b020-918f0e086d3f","slug":"complications","fullItemName":"Complications"},{"id":"82ccb916-06d4-5b29-91e4-90005f3db942","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"7305e6df-9b2c-5584-9412-54564432e382","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"8625eea6-53ec-5348-befa-a609ea64590f","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"273b1216-536e-59b4-8c39-547a97824ffa","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"68b86e3a-ee13-5ccd-9df0-a5c70c553251","fullItemName":"Management","slug":"management","subChapters":[{"id":"195394ca-067a-5cf3-bc4d-52a189d2cba6","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"4426193a-52c1-59b9-9222-77fb7169a3d1","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"78de19b8-8e80-551f-8112-456ce2e25bb0","slug":"amoxicillin","fullItemName":"Amoxicillin"},{"id":"73060223-dd90-59da-bae3-c706b5d24298","slug":"clarithromycin","fullItemName":"Clarithromycin"},{"id":"83f47301-e112-5f78-a79a-5c03a9de9537","slug":"co-amoxiclav","fullItemName":"Co-amoxiclav"},{"id":"b7240858-fbcc-5f20-8dcd-19f0b7221ac4","slug":"doxycycline","fullItemName":"Doxycycline"},{"id":"07828388-33ed-5e04-90b7-28a76fa26c6e","slug":"erythromycin","fullItemName":"Erythromycin"},{"id":"4600d0c1-4cd1-51ee-87a0-b660f0fa2165","slug":"flucloxacillin","fullItemName":"Flucloxacillin"},{"id":"0c0b7a3f-11e4-5b00-bd21-b66e49f9ad77","slug":"metronidazole","fullItemName":"Metronidazole"},{"id":"29987f8b-20b6-5c1f-8d23-183b415a04fb","slug":"analgesia","fullItemName":"Analgesia"}]},{"id":"4b09dc1a-8268-50d6-a164-227a73b3556e","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"d49b86e1-77b2-58e6-82c0-ea0aa7ee74ed","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"fe910063-69df-5218-bb78-36f5863db2a1","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"129f5233-2934-55ad-a561-4eb37861dc10","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"74d5b6b4-ef9d-5fc4-b41b-656b81a7ded8","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"44402335-ffeb-5e14-9e77-bb8278ef43d6","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"04d7d640-f586-53d9-ac59-804c10dd593d","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"c50af1ff-f157-5023-92b4-aa07b1c28d76","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"4426193a-52c1-59b9-9222-77fb7169a3d1","slug":"prescribing-information","fullItemName":"Prescribing information"},"subChapters":[{"id":"a94c3674-986b-52ff-9112-72105e18db59","slug":"contraindications-cautions","fullItemName":"Contraindications and cautions","depth":3,"htmlHeader":"<!-- begin field 30932790-595c-44af-8ea5-3514060bcbce --><h3>What are the contraindications and cautions for amoxicillin?</h3><!-- end field 30932790-595c-44af-8ea5-3514060bcbce -->","summary":"","htmlStringContent":"<!-- begin item 75e634f6-d001-4905-a3af-24616fe1525e --><!-- begin field 7ef869f3-2b38-4f04-b716-f29c0cac3086 --><ul><li><strong>Do not prescribe amoxicillin </strong>to people with:<ul><li>A <em>true </em>penicillin hypersensitivity. Gastrointestinal adverse effects alone (such as nausea, vomiting, or diarrhoea) do <em>not </em>constitute an allergy to penicillin. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/angio-oedema-anaphylaxis/\">Angio-oedema and anaphylaxis</a> for more information.</li><li>A history of severe immediate hypersensitivity reaction to cephalosporins — there is some evidence of partial cross-allergenicity. </li></ul></li><li><strong>Prescribe amoxicillin with caution to people with:</strong><ul><li>Chronic kidney disease (CKD) — reduce the dose of amoxicillin based on the estimated glomerular filtration rate (eGFR):<ul><li>If the eGFR is 10–30 mL/minute/1.73 m<sup>2</sup>, prescribe a maximum of 500 mg twice a day.</li><li>If the eGFR is less than 10 mL/minute/1.73 m<sup>2</sup>, prescribe a maximum of 500 mg once a day.</li></ul></li><li>Glandular fever (infective mononucleosis) — erythematous rashes common.</li><li>Acute lymphocytic leukaemia and chronic lymphocytic leukaemia — increased risk of erythematous rashes.</li><li>Cytomegalovirus infection — increased risk of erythematous rashes.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/cellulitis-acute/references/\">ABPI, 2017a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/cellulitis-acute/references/\">Joint Formulary Committee, 2019</a>]</p><!-- end field 7ef869f3-2b38-4f04-b716-f29c0cac3086 --><!-- end item 75e634f6-d001-4905-a3af-24616fe1525e -->","subChapters":[]},{"id":"0db71a06-b70a-5432-a5e9-e01ddd9e4b39","slug":"adverse-effects","fullItemName":"Adverse effects","depth":3,"htmlHeader":"<!-- begin field 8eada2ae-6f48-4e95-b8f8-eaa0907d3906 --><h3>What are the possible adverse effects of amoxicillin?</h3><!-- end field 8eada2ae-6f48-4e95-b8f8-eaa0907d3906 -->","summary":"","htmlStringContent":"<!-- begin item 0a4e5fe4-e7c8-4039-8541-c6b60b204805 --><!-- begin field 6d67d8e6-575f-4ac1-9957-9974737c2d01 --><ul><li><strong>The most common adverse effects of amoxicillin are </strong>nausea, vomiting, skin rash, and diarrhoea.<ul><li>Consider pseudomembranous colitis if a person develops severe diarrhoea during or after treatment with co-amoxiclav. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/diarrhoea-antibiotic-associated/\">Diarrhoea - antibiotic associated</a>.</li></ul></li><li><strong>Anaphylaxis (immediate or delayed) </strong>is a serious but rare adverse effect of amoxicillin. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/angio-oedema-anaphylaxis/\">Angio-oedema and anaphylaxis</a>.</li><li><strong>Other adverse effects include:</strong><ul><li>Rare — hepatitis, cholestatic jaundice; hyperkinesia, dizziness, convulsions; interstitial nephritis; leucopenia, thrombocytopenia, haemolytic anaemia.</li><li>Very rare — erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, bullous and exfoliative dermatitis and acute generalized exanthematous pustulosis.</li><li>Frequency not known — Jarisch–Herxheimer reaction.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/cellulitis-acute/references/\">ABPI, 2017a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/cellulitis-acute/references/\">Joint Formulary Committee, 2019</a>]</p><!-- end field 6d67d8e6-575f-4ac1-9957-9974737c2d01 --><!-- end item 0a4e5fe4-e7c8-4039-8541-c6b60b204805 -->","subChapters":[]},{"id":"d4544cd7-1ff6-5311-830c-9caaf6e73367","slug":"drug-interactions","fullItemName":"Drug interactions","depth":3,"htmlHeader":"<!-- begin field d6526247-fabe-4c36-ac44-ff94c884bacb --><h3>What are the possible drug interactions of amoxicillin?</h3><!-- end field d6526247-fabe-4c36-ac44-ff94c884bacb -->","summary":"","htmlStringContent":"<!-- begin item 74ef946a-f324-4197-a066-eb7d53324577 --><!-- begin field 76608bbc-1587-405f-8f2c-88bdb76490fb --><ul><li><strong>Possible drug interactions of co-amoxiclav include:</strong><ul><li>Allopurinol — be aware that concomitant use of allopurinol and co-amoxiclav may increase the incidence of skin rashes.<ul><li>Manufacturer advises to consider alternatives.</li></ul></li><li>Anticoagulants (for example warfarin) — penicillins potentially alter the anticoagulant effect of warfarin. <ul><li>Monitor the prothrombin time or international normalized ratio (INR) more closely with the addition or withdrawal of a penicillin. Adjustment of the anticoagulant dose may be necessary. </li></ul></li><li>Methotrexate — amoxicillin is predicted to increase the risk of toxicity when given with methotrexate.<ul><li>If concurrent treatment is indicated, monitor methotrexate levels more closely. One recommendation is to carry out twice weekly platelet and white cell counts for 2 weeks initially, with the measurement of methotrexate levels if toxicity is suspected.</li></ul></li><li>Probenecid — the renal tubular secretion of amoxicilin is decreased by probenecid. Concurrent use may result in increased and prolonged blood levels of amoxicillin, but not of clavulanic acid.<ul><li>Manufacturer recommends avoiding concurrent use.</li></ul></li></ul></li><li><strong>Oral hormonal contraception</strong> — additional contraceptive precautions are <em>not </em>required during or after courses of penicillins [<a class=\"bibliography-reference internal-reference\" href=\"/topics/cellulitis-acute/references/\">FSRH, 2017</a>].<ul><li>However, advise women on the importance of correct contraceptive practice if they experience vomiting or diarrhoea. For further information, see the section on vomiting or diarrhoea in the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/contraception-combined-hormonal-methods/\">Contraception - combined hormonal methods</a> <hyperlink-marker innertext=\"Contraception - combined hormonal methods\" refid=\"-494585\"></hyperlink-marker>and <a class=\"topic-reference external-reference\" href=\"/topics/contraception-progestogen-only-methods/\">Contraception - progestogen-only methods</a>.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/cellulitis-acute/references/\">ABPI, 2017a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/cellulitis-acute/references/\">Joint Formulary Committee, 2019</a>]</p><!-- end field 76608bbc-1587-405f-8f2c-88bdb76490fb --><!-- end item 74ef946a-f324-4197-a066-eb7d53324577 -->","subChapters":[]},{"id":"cd703221-1619-5e6c-a7fd-eb8ed0fab862","slug":"pregnancy-breastfeeding","fullItemName":"Pregnancy and breastfeeding","depth":3,"htmlHeader":"<!-- begin field 59002339-8259-412d-a648-e45717bef14e --><h3>Pregnancy and breastfeeding</h3><!-- end field 59002339-8259-412d-a648-e45717bef14e -->","summary":"","htmlStringContent":"<!-- begin item 00cdb074-f9a7-4deb-8a7e-ee86ef3ee19f --><!-- begin field 996f5d49-0f5b-4d97-8355-cf4d90b56ae0 --><ul><li><strong>Pregnancy</strong><ul><li>Amoxicillin is not known to be harmful in pregnancy [<a class=\"bibliography-reference internal-reference\" href=\"/topics/cellulitis-acute/references/\">Joint Formulary Committee, 2019</a>]. </li><li>The vast majority of the large amount of available data shows no increased risk of congenital malformation, spontaneous abortion, intrauterine death, low birth weight, preterm delivery, or neonatal complications following maternal exposure to therapeutic doses of penicillins [<a class=\"bibliography-reference internal-reference\" href=\"/topics/cellulitis-acute/references/\">UKTIS, 2017a</a>].</li></ul></li><li><strong>Breastfeeding</strong><ul><li>Trace amounts of amoxicillin are found in breastmilk, but it is appropriate to use in women who are breastfeeding [<a class=\"bibliography-reference internal-reference\" href=\"/topics/cellulitis-acute/references/\">Joint Formulary Committee, 2019</a>].</li><li>Penicillins (and cephalosporins) are the antibiotics of choice in women who are breastfeeding [<a class=\"bibliography-reference internal-reference\" href=\"/topics/cellulitis-acute/references/\">Kearney, 2016</a>].</li></ul></li></ul><!-- end field 996f5d49-0f5b-4d97-8355-cf4d90b56ae0 --><!-- end item 00cdb074-f9a7-4deb-8a7e-ee86ef3ee19f -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}